Synapse - Find an Expert

5608 Results

Reply to C. Anderson and J.M. Buatti

Journal Article

Ward, M. M.; Ullrich, F.; Rushton, G.; Bajorin, D. F.; Jacobson, G. M.; Lynch, C. F.
Journal of Oncology Practice (2014)

Fulltext@MSK | Save

Oncogenic RAF mutants that signal as functional dimers are resistant to current RAF inhibitors but sensitive to a novel inhibitor of RAF dimer kinase activity

Meeting Abstract

Yao, Z.; Torres, M.; Wei, M.; Hanrahan, A.; Abdel-Wahab, O.; Solit, D.; Luo, L. S.; Poulikakos, P.; Rosen, N.
Cancer Research (2014)

Fulltext@MSK | Save

Comprehensive characterization of urothelial bladder cancer: A TCGA Project update

Meeting Abstract

Weinstein, J. N.; Kim, J.; Creighton, C. J.; Akbani, R.; Hoadley, K. A.; Kim, W. Y.; Morgan, M. B.; Hinoue, T.; Cherniack, A.; Su, X.; more...
Cancer Research (2014)

Fulltext@MSK | Save

Identification of genomic alterations associated with metastasis in clear cell renal cell carcinoma

Meeting Abstract

Thodima, V. J.; Gowrishankar, B.; Molina, A.; Georges, M.; Chaganti, R. S. K.; Motzer, R. J.; Houldsworth, J.
Cancer Research (2014)

Fulltext@MSK | Save

The antitumor effects of PI3K beta inhibitors in PTEN negative prostate cancer are enhanced by inhibition of reactivated PI3K alpha signaling

Meeting Abstract

Schwartz, S.; Carver, B. S.; Wongvipat, J.; Rodrik-Outmezguine, V. ; Destanchina, E.; Trigwell, C.; Barry, S.; Baselga, J.; Chandarlapaty, S.; Scher, H. I.; more...
Cancer Research (2014)

Fulltext@MSK | Save

ARN-509 in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with abiraterone acetate (AA)

Meeting Abstract

Rathkopf, D. E.; Antonarakis, E. S.; Shore, N. D.; Tutrone, R.; Alumkal, J. J.; Ryan, C. J.; Saleh, M. N.; Hauke, R. J.; Bandekar, R.; Maneval, E. C.; more...
Cancer Research (2014)

Fulltext@MSK | Save

Dual lineage inhibition of ETV1 and KIT disrupts the ETV1-KIT feed forward circuit and potentiates imatinib antitumor effect in GIST oncogenesis

Meeting Abstract

Ran, L.; Sirota, I.; Cao, Z.; Murphy, D.; Shukla, S.; Rossi, F.; Wongvipat, J.; Tap, W. D.; Besmer, P.; Antonescu, C. R.; more...
Cancer Research (2014)

Fulltext@MSK | Save

Bevacizumab (BEV) and risk of arterial (ATE) and venous thromboembolism (VTE) in metastatic castration-resistant prostate cancer (mCRPC) patients treated on CALGB 90401(ALLIANCE)

Meeting Abstract

Patel, J. N.; Jiang, C.; Hertz, D. L.; Mulkey, F. A.; Friedman, P. N.; Halabi, S.; Ratain, M. J.; Morris, M. J.; Small, E. J.; Owzar, K.; more...
Cancer Research (2014)

Fulltext@MSK | Save

A phase II study of afatinib (A) in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab (T) refractory esophagogastric (EG) cancer